sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Tourette Syndrome: Epidemiology Forecasting Intelligence

Tourette Syndrome: Epidemiology Forecasting Intelligence

Home / Categories / Healthcare
Tourette Syndrome: Epidemiology Forecasting Intelligence
Tourette Syndrome: Epidemiology Forecasting Intelligence
Report Code
RO1/114/1318

Publish Date
01/Mar/2019

Pages
50-70
PRICE
$ 2500/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 6000/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
1. Report Introduction
2. Tourette Syndrome Epidemiology Overview at a Glance
3. Market Share Distribution of Tourette Syndrome
4. Disease Background and Overview: Tourette Syndrome
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Tourette Syndrome Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Tourette Syndrome by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Tourette Syndrome
7.3. Sub-Type Specific cases of Tourette Syndrome*
7.4. Sex- Specific Cases of Tourette Syndrome*
7.5. Diagnosed Cases of Tourette Syndrome
7.6. Treated Cases of Tourette Syndrome
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Tourette Syndrome
8.1.3. Sub-Type Specific cases of Tourette Syndrome*
8.1.4. Sex- Specific Cases of Tourette Syndrome*
8.1.5. Diagnosed Cases of Tourette Syndrome
8.1.6. Treated Cases of Tourette Syndrome
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Tourette Syndrome
8.2.3. Sub-Type Specific cases of Tourette Syndrome*
8.2.4. Sex- Specific Cases of Tourette Syndrome*
8.2.5. Diagnosed Cases of Tourette Syndrome
8.2.6. Treated Cases of Tourette Syndrome
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Tourette Syndrome
8.3.3. Sub-Type Specific cases of Tourette Syndrome*
8.3.4. Sex- Specific Cases of Tourette Syndrome*
8.3.5. Diagnosed Cases of Tourette Syndrome
8.3.6. Treated Cases of Tourette Syndrome
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Tourette Syndrome
8.4.3. Sub-Type Specific cases of Tourette Syndrome*
8.4.4. Sex- Specific Cases of Tourette Syndrome*
8.4.5. Diagnosed Cases of Tourette Syndrome
8.4.6. Treated Cases of Tourette Syndrome
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Tourette Syndrome
8.5.3. Sub-Type Specific cases of Tourette Syndrome*
8.5.4. Sex- Specific Cases of Tourette Syndrome*
8.5.5. Diagnosed Cases of Tourette Syndrome
8.5.6. Treated Cases of Tourette Syndrome
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Tourette Syndrome
9.3. Sub-Type Specific cases of Tourette Syndrome*
9.4. Sex- Specific Cases of Tourette Syndrome*
9.5. Diagnosed Cases of Tourette Syndrome
9.6. Treated Cases of Tourette Syndrome
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com